Table 2.
DALYs and ASDR of lung cancer attributable to high fasting plasma glucose in 1990 and 2021, and EAPC of ASDR from 1990 to 2021.
| Characteristics | 1990 | 2021 | 1990–2021 | ||
|---|---|---|---|---|---|
| Number of DALYs (95%UI) | ASDR per 100,000 (95%UI) | Number of DALYs (95%UI) | ASDR per 100,000 (95%UI) | EAPC of ASDR (95%CI) | |
| Global | 455,679.34 (−93,890.52 to 1,006,142.59) | 11.33 (−2.34 to 25.05) | 1,085,022.95 (−216,348.64 to 2,493,471.39) | 12.43 (−2.48 to 28.54) | 0.39 (0.26 to 0.52) |
| Sex | |||||
| Male | 345,026.9 (−69,879.93 to 758,151.90) | 18.64 (−3.78 to 41.19) | 741,592.98 (−147,696.7 to 1,701,245.48) | 18.21 (−3.63 to 41.86) | 0.05 (−0.08 to 0.18) |
| Female | 110,652.44 (−24,010.58 to 250,054.73) | 5.16 (−1.12 to 11.66) | 343,429.97 (−68,764.7 to 777,314.58) | 7.41 (−1.48 to 16.77) | 1.17 (1.02 to 1.31) |
| SDI region | |||||
| High SDI | 193,061.13 (−39,665.34 to 423,164.75) | 17.48 (−3.59 to 38.38) | 347,423.64 (−70,133.23 to 781,437.06) | 16.61 (−3.36 to 37.24) | −0.14 (−0.33 to 0.04) |
| High-middle SDI | 141,894.55 (−28,852.97 to 319,090.41) | 13.79 (−2.81 to 30.98) | 334,729.42 (−67,415.17 to 759,647.56) | 16.55 (−3.34 to 37.56) | 0.76 (0.61 to 0.92) |
| Middle SDI | 93,938.58 (−19,671.34 to 208,713.28) | 8.90 (−1.86 to 19.77) | 303,705.26 (−59,830.65 to 702,205.72) | 11.07 (−2.18 to 25.62) | 0.83 (0.73 to 0.93) |
| Low-middle SDI | 21,140.70 (−4,426.12 to 45,569.90) | 3.40 (−0.71 to 7.38) | 82,911.07 (−16,043.68 to 189,192.47) | 5.65 (−1.09 to 12.91) | 1.72 (1.70 to 1.75) |
| Low SDI | 4,974.69 (−1,008.11 to 11,172.22) | 2.16 (−0.44 to 4.83) | 14,919.82 (−2,824.95 to 33,222.74) | 2.93 (−0.55 to 6.51) | 0.93 (0.83 to 1.03) |
ASDR, age-standardized DALYs rate; CI, confidential interval; DALY, disability-adjusted life-year; EAPC, estimated annual percentage change; SDI, sociodemographic index; UI, uncertainty interval.